[go: up one dir, main page]

GB202115072D0 - Assay - Google Patents

Assay

Info

Publication number
GB202115072D0
GB202115072D0 GBGB2115072.7A GB202115072A GB202115072D0 GB 202115072 D0 GB202115072 D0 GB 202115072D0 GB 202115072 A GB202115072 A GB 202115072A GB 202115072 D0 GB202115072 D0 GB 202115072D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2115072.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB2115072.7A priority Critical patent/GB202115072D0/en
Publication of GB202115072D0 publication Critical patent/GB202115072D0/en
Priority to PCT/EP2022/079103 priority patent/WO2023067002A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
GBGB2115072.7A 2021-10-21 2021-10-21 Assay Ceased GB202115072D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2115072.7A GB202115072D0 (en) 2021-10-21 2021-10-21 Assay
PCT/EP2022/079103 WO2023067002A1 (en) 2021-10-21 2022-10-19 In vitro potency assay for protein-based meningococcal vaccines using monoclonal antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2115072.7A GB202115072D0 (en) 2021-10-21 2021-10-21 Assay

Publications (1)

Publication Number Publication Date
GB202115072D0 true GB202115072D0 (en) 2021-12-08

Family

ID=78805963

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2115072.7A Ceased GB202115072D0 (en) 2021-10-21 2021-10-21 Assay

Country Status (2)

Country Link
GB (1) GB202115072D0 (en)
WO (1) WO2023067002A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848965A1 (en) 1978-11-11 1980-05-22 Behringwerke Ag METHOD FOR PRODUCING MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING THEM
US6180111B1 (en) 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
WO2009143168A2 (en) * 2008-05-19 2009-11-26 Novartis Ag Vaccine assays
WO2012031271A1 (en) * 2010-09-04 2012-03-08 Novartis Ag Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
JP2015517089A (en) 2012-03-08 2015-06-18 ノバルティス アーゲー In vitro efficacy assay for protein-based meningococcal vaccines

Also Published As

Publication number Publication date
WO2023067002A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
GB202011617D0 (en) Assay
GB201807409D0 (en) Assay
GB2600719B (en) Fluorescence assay
GB201819187D0 (en) Assay
GB202008994D0 (en) Assay method
IL307174A (en) Assay
GB202016699D0 (en) Antibody assay
GB2616452B (en) Assay
GB202119033D0 (en) Assay
GB202117513D0 (en) Assay
GB202115077D0 (en) Assay
GB202115072D0 (en) Assay
GB202112296D0 (en) Assay
GB202109886D0 (en) Assay
GB202108853D0 (en) Assay
GB202105117D0 (en) Assay
GB202015211D0 (en) Assay
GB202015122D0 (en) Assay
GB202014570D0 (en) Complementome assay
GB201905090D0 (en) Assay device
GB201903009D0 (en) Assay device
EP4060017A4 (en) Assay chip
GB202006987D0 (en) Improved assay
GB202001496D0 (en) Improved assay
GB202001203D0 (en) Improved assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)